These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 23619114

  • 1. Spontaneous epidural hematoma in a child with inherited factor XIII deficiency.
    Farah RA, Al Danaf JZ, Chahinian RA, Braiteh NT, Al Ojaimi NF, Cairo A, Farhat H, Mantoura JR.
    J Pediatr Hematol Oncol; 2014 Jan; 36(1):62-5. PubMed ID: 23619114
    [Abstract] [Full Text] [Related]

  • 2. Efficacy and safety of prophylactic treatment with plasma-derived factor XIII concentrate (human) in patients with congenital factor XIII deficiency.
    Ashley C, Chang E, Davis J, Mangione A, Frame V, Nugent DJ.
    Haemophilia; 2015 Jan; 21(1):102-8. PubMed ID: 25377187
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Molecular characterization of a novel mutation in the factor XIII a subunit gene associated with a severe defect: importance of prophylactic substitution.
    Morange P, Trigui N, Frère C, Chambost H, Pouymayou C, Uters M, Boucly C, Juhan-Vague I, de Mazancourt P.
    Blood Coagul Fibrinolysis; 2009 Oct; 20(7):605-6. PubMed ID: 19713833
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Pharmacokinetics of recombinant factor XIII in young children with congenital FXIII deficiency and comparison with older patients.
    Williams M, Will A, Stenmo C, Rosholm A, Tehranchi R.
    Haemophilia; 2014 Jan; 20(1):99-105. PubMed ID: 23834599
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results.
    Kerlin BA, Inbal A, Will A, Williams M, Garly ML, Jacobsen L, Kearney SL.
    J Thromb Haemost; 2017 Aug; 15(8):1601-1606. PubMed ID: 28581691
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Severe congenital factor XIII deficiency caused by novel W187X and G273V mutations in the F13A gene; diagnosis and classification according to the ISTH/SSC guidelines.
    Souri M, Biswas A, Misawa M, Omura H, Ichinose A.
    Haemophilia; 2014 Mar; 20(2):255-62. PubMed ID: 24286209
    [Abstract] [Full Text] [Related]

  • 13. Use of Factor XIII (FXIII) concentrate in patients with congenital FXIII deficiency undergoing surgical procedures.
    Janbain M, Nugent DJ, Powell JS, St-Louis J, Frame VB, Leissinger CA.
    Transfusion; 2015 Jan; 55(1):45-50. PubMed ID: 25070582
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Alloantibodies against the B subunit of plasma factor XIII developed in its congenital deficiency.
    Wada H, Souri M, Matsumoto R, Sugihara T, Ichinose A.
    Thromb Haemost; 2013 Apr; 109(4):661-8. PubMed ID: 23407795
    [Abstract] [Full Text] [Related]

  • 17. Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family.
    Onland W, Böing AN, Meijer AB, Schaap MC, Nieuwland R, Haasnoot K, Sturk A, Peters M.
    Haemophilia; 2005 Sep; 11(5):539-47. PubMed ID: 16128900
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.